Covid 19 has caused severe disruptions for many people. According to WHO, as of 31 December 2020, COVID-19 had infected over 82 million people and killed more than 1.8 million worldwide. This pandemic raised the interest of many researchers to find the drug and treatment plans for COVID-19. So, now it’s interesting to know the […]
Read More →Drug developers need to ensure that the data submitted to regulatory bodies is definitive from an ethical point and make efficient treatment decisions to ultimately affect patient health. So, for these two reasons, the quality of clinical trial data is crucial, and to achieve this quality data, one needs to have proper data management in […]
Read More →Dermatology clinical trials present many challenges to researchers over clinical trials in other therapeutic areas. These include finding perfect clinical trial sites, patient recruitment, patient retention, etc. These challenges are more prominent in rare skin diseases. Dermatology is the branch of medicine which deals with the skin. Dermatologists diagnose diseases related to skin, hair, nails, […]
Read More →Clinical data management (CDM) is a critical tool that helps to generate high-quality, reliable, and statistically sound data from clinical trials. Drug companies ensure to generate trustworthy and quality data to gain approval from the regulators for new drugs. Thus, an efficient CDM in a clinical trial is important to advance the drug development process. […]
Read More →After changes in the regulatory system, Japan has become the largest market for clinical trials in the Asia-Pacific region for both local and global studies, and Japan is now a country of choice in clinical development maps. But still, you need a proper strategy to accelerate the drug development process in japan. Previously it would […]
Read More →Most errors and technical failures in clinical trials arise due to the improper selection of clinical trial designs. The clinical trial design selection will have a strong impact on the cost and time associated with clinical trials. The expected outcomes shall be thought and carefully addressed while designing a clinical trial. The selection of clinical […]
Read More →Sourcing or importing the IMPs and their supportive products is a challenging process for many researchers and this is more prominent with the countries like China and Japan where understanding the regulations is difficult due to the language barriers and rapid changing norms for making imports. Many key players in logistics are unclear about the […]
Read More →Getting the study drug at the right time is challenging for any clinical trial, and this is more prominent with multi-regional clinical trials. To import and have the IMPs and ancillaries at the clinical trial sites in time, the sponsors need to have the right people, processes, facilities, and technology in place. Generally, the sites […]
Read More →As clinical trials have become increasingly global and complex, ancillaries have grown in volume, type, and expectations. The clinical trials supplies market is projected to reach USD 2.5 billion by 2025 owing to the logistics services with the increasing number of clinical trials involving temperature-sensitive drugs. Currently, North America is the largest market for clinical […]
Read More →The conduct of clinical trials is a demanding process. This requires not only the hiring of resources to perform various activities but also the material to support to actually execute different activities and processes. Some of these materials can be investigational products. But, a vast number of products could be non-investigational products required for the […]
Read More →